1. Balancing Efficacy and Safety: Ensuring the modified dose still effectively combats the cancer. 2. Patient Compliance: Patients may struggle with altered treatment schedules or reduced doses, affecting adherence. 3. Limited Data: There is often a lack of comprehensive data on the outcomes of dose modifications, making it challenging to predict long-term results.